BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15157994)

  • 1. Lack of association between Alzheimer's disease and the promoter region polymorphisms of the nicastrin gene.
    Orlacchio A; Kawarai T; Polidoro M; Paterson AD; Rogaeva E; Orlacchio A; St George-Hyslop PH; Bernardi G
    Neurosci Lett; 2004 Jun; 363(1):49-53. PubMed ID: 15157994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between promoter polymorphisms of the nicastrin gene and sporadic Alzheimer's disease in North Chinese Han population.
    Ma Z; Han D; Zuo X; Wang F; Jia J
    Neurosci Lett; 2009 Jul; 458(3):136-9. PubMed ID: 19394408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No replication of the association between the Nicastrin gene and familial early-onset Alzheimer's disease.
    Cousin E; Hannequin D; Macé S; Dubois B; Ricard S; Génin E; Brun C; Chansac C; Pradier L; Frebourg T; Brice A; Campion D; Deleuze JF
    Neurosci Lett; 2003 Dec; 353(2):153-5. PubMed ID: 14664923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms.
    Orlacchio A; Kawarai T; Polidoro M; Stefani A; Orlacchio A; St George-Hyslop PH; Bernardi G
    Neurosci Lett; 2002 Nov; 333(2):115-8. PubMed ID: 12419494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample.
    Dermaut B; Theuns J; Sleegers K; Hasegawa H; Van den Broeck M; Vennekens K; Corsmit E; St George-Hyslop P; Cruts M; van Duijn CM; Van Broeckhoven C
    Am J Hum Genet; 2002 Jun; 70(6):1568-74. PubMed ID: 11992262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the nicastrin promoter rs10752637 polymorphism and its association with Alzheimer's disease.
    Zhong L; Dong-hai Q; Hong-ying L; Qing-feng L
    Eur J Neurosci; 2009 Nov; 30(9):1831-6. PubMed ID: 19840113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible association of nicastrin polymorphisms and Alzheimer disease in the Finnish population.
    Helisalmi S; Dermaut B; Hiltunen M; Mannermaa A; Van den Broeck M; Lehtovirta M; Koivisto AM; Iivonen S; Cruts M; Soininen H; Van Broeckhoven C
    Neurology; 2004 Jul; 63(1):173-5. PubMed ID: 15249634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
    Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and genetic analysis of haplotypic sequence variation at the nicastrin genomic locus.
    Hamilton G; Killick R; ; ; Lambert JC; Amouyel P; ; Carrasquillo MM; Pankratz VS; Graff-Radford NR; Dickson DW; Petersen RC; Younkin SG; Powell JF; Wade-Martins R
    Neurobiol Aging; 2012 Aug; 33(8):1848.e1-13. PubMed ID: 22405046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicastrin gene in familial and sporadic Alzheimer's disease.
    Confaloni A; Terreni L; Piscopo P; Crestini A; Campeggi LM; Frigerio CS; Blotta I; Perri M; Di Natale M; Maletta R; Marcon G; Franceschi M; Bruni AC; Forloni G; Cantafora A
    Neurosci Lett; 2003 Dec; 353(1):61-5. PubMed ID: 14642438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation in apolipoprotein D and Alzheimer's disease.
    Helisalmi S; Hiltunen M; Vepsäläinen S; Iivonen S; Corder EH; Lehtovirta M; Mannermaa A; Koivisto AM; Soininen H
    J Neurol; 2004 Aug; 251(8):951-7. PubMed ID: 15316799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common GSAP promoter variant contributes to Alzheimer's disease liability.
    Zhu M; Tao Y; He Q; Gao H; Song F; Sun YM; Li HL; Wu ZY; Saffen D
    Neurobiol Aging; 2014 Nov; 35(11):2656.e1-2656.e7. PubMed ID: 25037285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
    Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the Neprilysin gene with susceptibility to late-onset Alzheimer's disease.
    Sakai A; Ujike H; Nakata K; Takehisa Y; Imamura T; Uchida N; Kanzaki A; Yamamoto M; Fujisawa Y; Okumura K; Kuroda S
    Dement Geriatr Cogn Disord; 2004; 17(3):164-9. PubMed ID: 14739539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease.
    Lupton MK; Proitsi P; Danillidou M; Tsolaki M; Hamilton G; Wroe R; Pritchard M; Lord K; Martin BM; Kloszewska I; Soininen H; Mecocci P; Vellas B; Harold D; Hollingworth P; Lovestone S; Powell JF
    PLoS One; 2011 Feb; 6(2):e17298. PubMed ID: 21364883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants regulating ZBTB4 are associated with age-at-onset of Alzheimer's disease.
    Blue EE; Yu CE; Thornton TA; Chapman NH; Kernfeld E; Jiang N; Shively KM; Buckingham KJ; Marvin CT; Bamshad MJ; Bird TD; Wijsman EM
    Genes Brain Behav; 2018 Jul; 17(6):e12429. PubMed ID: 29045054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer's disease mouse model.
    Sesele K; Thanopoulou K; Paouri E; Tsefou E; Klinakis A; Georgopoulos S
    Aging Cell; 2013 Dec; 12(6):1032-40. PubMed ID: 23826707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
    Bekris LM; Galloway NM; Millard S; Lockhart D; Li G; Galasko DR; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Leverenz JB; Seubert P; Tsuang DW; Peskind ER; Yu CE
    Neurobiol Aging; 2011 Mar; 32(3):556.e13-23. PubMed ID: 21196064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.
    Wang JC; Kwon JM; Shah P; Morris JC; Goate A
    Neurology; 2000 Dec; 55(11):1644-9. PubMed ID: 11113217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.
    Artiga MJ; Bullido MJ; Frank A; Sastre I; Recuero M; García MA; Lendon CL; Han SW; Morris JC; Vázquez J; Goate A; Valdivieso F
    Hum Mol Genet; 1998 Nov; 7(12):1887-92. PubMed ID: 9811931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.